AbbVie Share Repurchase Program - Amount Remaining decreased by 37.9% to $1.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 37.9%, from $2.90B to $1.80B.
share_repurchase_program_amount_remaining| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.60B | $2.60B | $1.40B | $1.40B | $1.40B | $4.80B | $4.80B | $4.80B | $3.90B | $3.90B | $3.90B | $2.90B | $2.90B | $2.90B | $1.80B |
| QoQ Change | — | +0.0% | -46.2% | +0.0% | +0.0% | +242.9% | +0.0% | +0.0% | -18.8% | +0.0% | +0.0% | -25.6% | +0.0% | +0.0% | -37.9% |
| YoY Change | — | — | — | -46.2% | -46.2% | +242.9% | +242.9% | +242.9% | -18.8% | -18.8% | -18.8% | -25.6% | -25.6% | -25.6% | -37.9% |